Terri Sewell is not setting off any Google News alarms this week. Three posts on Bluesky, two of them automated feed items, and a photo from a meeting with UK parliamentary colleagues. Quiet news cycle. But her disclosed trading record is a different conversation. On March 25, 2026, Sewell filed two sales on the same day: Mix ($15K-$50K) and GE HealthCare Technologies ($1K-$15K). The GE HealthCare sale is the one worth sitting with. Sewell sits on the House Ways and Means Committee, which, per its own remit, covers health policy and Medicare. GE HealthCare is a $15-billion medical imaging and diagnostics company. Both of those things are true at the same time.
The Social Footprint This Week: Three Posts and a Photo
Sewell's public profile right now is low voltage. The top Bluesky content is a delegation photo: Sewell and Rep. Robin Kelly meeting with members of the UK Parliamentary Black Caucus, including MP Diane Abbott. It's the kind of international engagement that generates a single press release and nothing else.
The other two Bluesky hits are RSS-style feed aggregators pushing her official congressional updates. There are zero Google News stories in the last 24 hours. For a 14-year incumbent from Alabama's 7th district, that's a normal Tuesday.
Which means this is a good week to look at what she's been doing with her brokerage account.
Two Sales, One Day, One That Raises the Question
On March 25, 2026, Sewell's disclosed filings show two exits.
The first: Mix (ticker: TPR), the luxury-goods holding company that owns Coach and Kate Spade. Sale range $15K-$50K. Mix has nothing to do with Sewell's committee assignments. It's a consumer discretionary play, and her off-the-floor stock decisions on consumer names don't carry a structural oversight angle. This is just a trade.
The second: GE HealthCare Technologies (ticker: GEHC). Sale range $1K-$15K. Smaller in dollar terms, larger in context. GE HealthCare makes MRI machines, CT scanners, ultrasound equipment, and AI-assisted diagnostics. Its revenue runs heavily through hospital systems, many of which are Medicare-reimbursed. The House Ways and Means Committee, on which Sewell serves, has direct jurisdiction over Medicare policy. That committee overlap is flagged in Blind Trust's disclosure tracker.
Members are required to disclose. They are not required to divest, recuse, or explain. That's the rule. Yes, really.
The Alpha Record: 2 for 4, Mean of -2.7%
Sewell's full scored trade sample is four trades. She's positive on two, negative on two, for a mean 30-day alpha of -2.7% against the S&P 500. It's a coin flip with a slight lean toward the wrong side.
The best trade in the sample: an Apple purchase on April 10, 2025 ($1K-$15K range), which produced a 30-day alpha of +5.6%. No committee overlap, no structural angle. Just a member who bought Apple in April 2025 and timed it reasonably well.
The second-best: an Nvidia purchase on the same date, April 10, 2025, same dollar range, +1.4% alpha. Again, no committee overlap. A small-dollar tech bet that paid modestly.
Then the March 25, 2026 sales. The Mix exit came in at -8.3% alpha over 30 days, meaning the stock moved against her after she sold. The GE HealthCare exit: -9.4% alpha. The sales that most raised the structural question also produced the worst outcomes in the sample.
To be precise about the record: 2 positive out of 4 scored trades. Mean alpha of -2.7%. The interpretation is yours.
Ways and Means: What the Committee Actually Covers
Sewell's committee assignments are worth spelling out precisely, because the instinct to call every trade a conflict is as sloppy as calling none of them one.
She sits on the full Ways and Means Committee, plus three subcommittees: Oversight, Social Security, and Trade. She's also on the House Administration Committee (elections subcommittee) and the Joint Committee on Printing.
The healthcare connection runs through Ways and Means because the committee controls Medicare and Medicaid financing. Bills setting reimbursement rates, coverage rules, and drug pricing all move through this committee before they get to the floor. GE HealthCare's business model depends materially on what Medicare pays for imaging procedures.
The banking bills Sewell voted on in May 2026 are a different story. The American Access to Banking Act and the Community Bank Deposit Access Act passed on May 20, both receiving Sewell's Yea. Those bills run through Financial Services jurisdiction, not Ways and Means. A floor vote on a banking bill by a Ways and Means member is just a vote. There's no oversight angle there, and we're not going to manufacture one.
The Floor Votes: What's Worth Noting and What Is not
Sewell voted Yea on four bills that cleared the House on May 20, 2026: the American Access to Banking Act, the Community Bank Deposit Access Act, the Keeping Deposits Local Act, and the 9/11 Commemorative Coin Act. All passed.
She voted Nay on the Veterans 2nd Amendment Protection Act (passed anyway), Nay on the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act (also passed), and Nay on a FISA extension bill that ultimately failed on June 11.
None of these votes overlap with her March 25 trades in timing or subject matter. The vote-trade overlap field in her file is empty. The banking votes came two months after the sales. There's nothing to map here, so we're not going to map it.
The receipts are public. Make of them what you make of them.
The GEHC Question, Stated Plainly
GE HealthCare was spun off from GE in January 2023. Since then it's traded as an independent medical-technology company, subject to the same Medicare reimbursement environment that Ways and Means shapes. Sewell sold between $1,000 and $15,000 worth of GEHC on March 25, 2026. Her 30-day alpha on that sale was -9.4%, which means the stock's net move in the 30 days after her sale underperformed the S&P by 9.4 percentage points. She sold before a rough stretch.
The timing is what it is. She sits on the committee that writes Medicare policy. She held a position in a company that runs on Medicare reimbursements. She sold it. The 30-day performance went against her in alpha terms, meaning the price dropped more than the market after she exited.
We are not asserting intent. We are reading the public filing, out loud, in chronological order.
The Mix Trade: Less Drama, Still a Number
The Mix sale is the larger of the two in dollar terms ($15K-$50K range) and the less interesting one structurally. TPR has no footprint in any of Sewell's committee jurisdictions. It's a handbag company. Ways and Means does cover trade policy, and Mix imports from overseas manufacturing, but that's a stretch that doesn't survive a straight face.
The -8.3% alpha on the TPR exit means, like GEHC, the stock moved the wrong way after she sold. Both March 25 sales underperformed the market over the following 30 days. That's the outcome for 2 of her 4 scored trades, and they happen to be the two most recent ones.
Her overall record: 2-for-4, mean alpha -2.7%. Not a superforecaster. Not a scandal by the numbers alone.
Where This Sits
Sewell is a senior Ways and Means member in a quiet news week. The Bluesky engagement is soft. The Google News column is empty. But the disclosure record shows a member who sold a healthcare-sector stock that sits inside her committee's jurisdiction, on the same day she sold a luxury-goods name that doesn't.
The full disclosure record is available. The committee assignments are public. The trade dates are filed. Four trades, two winners, two losers, mean alpha in the red.
Take that for what it's worth.